Physiomics (LON:PYC) Shares Down 6.4% – Should You Sell?

Physiomics Plc (LON:PYC)’s stock price traded down 6.4% during mid-day trading on Monday . The company traded as low as GBX 0.76 ($0.01) and last traded at GBX 0.76 ($0.01). 1,361,472 shares changed hands during trading, a decline of 20% from the average session volume of 1,711,334 shares. The stock had previously closed at GBX 0.81 ($0.01).

Physiomics Stock Down 6.4 %

The firm’s 50-day simple moving average is GBX 0.69 and its 200 day simple moving average is GBX 0.75. The stock has a market capitalization of £1.55 million, a P/E ratio of -13.83 and a beta of 1.69.

Insider Buying and Selling

In other news, insider Peter Sargent bought 459,090 shares of the business’s stock in a transaction on Thursday, November 7th. The stock was purchased at an average price of GBX 1 ($0.01) per share, with a total value of £4,590.90 ($5,775.44). 4.18% of the stock is currently owned by company insiders.

Physiomics Company Profile

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.